SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Brooks Laboratories informs about trading window closure

25 Mar 2026 Evaluate
Brooks Laboratories has informed that the ‘Trading Restriction Period’ shall be made applicable from the end of every quarter till 48 hours after the declaration of Financial Results. In view of the aforesaid, it is hereby intimated that the Trading Window for dealing in the securities of the Company will be closed for the Designated Persons and their immediate relatives effective from Wednesday, 1st April 2026, until 48 hours after the declaration of Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March 2026. The details of the Board Meeting and opening of the Trading Window shall be intimated in due course.

The above information is a part of company’s filings submitted to BSE.

Brooks Laboratories Share Price

68.00 -2.00 (-2.86%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×